Log In
Print
BCIQ
Print
Print this Print this
 

COG112

  Manage Alerts
Collapse Summary General Information
Company Cognosci Inc.
DescriptionApolipoprotein E mimetic peptide
Molecular Target Nuclear factor of kappa light polypeptide gene enhancer in B cells 1 (NF-kB) (NFKB1) (p105) (p50)
Mechanism of Action 
Therapeutic ModalityPeptide
Latest Stage of DevelopmentPreclinical
Standard IndicationMultiple sclerosis (MS)
Indication DetailsTreat Multiple sclerosis (MS)
Regulatory Designation

Partner


 Product Details
 Archive Items are loading loading
Get a free BioCentury trial today